AU4967193A - Use of macrolide compounds for the treatment of reversible obstructive airways disease - Google Patents
Use of macrolide compounds for the treatment of reversible obstructive airways diseaseInfo
- Publication number
- AU4967193A AU4967193A AU49671/93A AU4967193A AU4967193A AU 4967193 A AU4967193 A AU 4967193A AU 49671/93 A AU49671/93 A AU 49671/93A AU 4967193 A AU4967193 A AU 4967193A AU 4967193 A AU4967193 A AU 4967193A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- obstructive airways
- airways disease
- macrolide compounds
- reversible obstructive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9218027 | 1992-08-25 | ||
GB929218027A GB9218027D0 (en) | 1992-08-25 | 1992-08-25 | Novel method of treatment |
PCT/GB1993/001769 WO1994004148A1 (fr) | 1992-08-25 | 1993-08-20 | Utilisation de composes de la classe des macrolides dans le traitement de maladies entrainant une obstruction reversible des voies aeriennes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4967193A true AU4967193A (en) | 1994-03-15 |
Family
ID=10720906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49671/93A Abandoned AU4967193A (en) | 1992-08-25 | 1993-08-20 | Use of macrolide compounds for the treatment of reversible obstructive airways disease |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU4967193A (fr) |
GB (1) | GB9218027D0 (fr) |
IL (1) | IL106751A0 (fr) |
MX (1) | MX9305152A (fr) |
WO (1) | WO1994004148A1 (fr) |
ZA (1) | ZA936137B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP223198A0 (en) * | 1998-03-06 | 1998-04-02 | Fujisawa Pharmaceutical Co., Ltd. | New use |
GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
PT1666028E (pt) | 1999-10-29 | 2010-06-15 | Novartis Ag | Composições de pós anidros com melhor dispersividade |
US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
AR035411A1 (es) * | 2000-12-29 | 2004-05-26 | Fujisawa Pharmaceutical Co | Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto |
JP2007518692A (ja) * | 2004-01-20 | 2007-07-12 | アステラス製薬株式会社 | 勃起不全治療方法 |
MX2019005504A (es) | 2016-11-10 | 2019-08-12 | Novartis Ag | Potenciadores de bmp. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU630866B2 (en) * | 1987-12-09 | 1992-11-12 | Fisons Plc | Macrocyclic compounds |
IE64214B1 (en) * | 1989-06-06 | 1995-07-26 | Fujisawa Pharmaceutical Co | Macrolides for the treatment of reversible obstructive airways diseases |
GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
CA2054983A1 (fr) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Composition suspensible et procede de fabrication |
-
1992
- 1992-08-25 GB GB929218027A patent/GB9218027D0/en active Pending
-
1993
- 1993-08-20 AU AU49671/93A patent/AU4967193A/en not_active Abandoned
- 1993-08-20 WO PCT/GB1993/001769 patent/WO1994004148A1/fr active Application Filing
- 1993-08-20 ZA ZA936137A patent/ZA936137B/xx unknown
- 1993-08-20 IL IL106751A patent/IL106751A0/xx unknown
- 1993-08-25 MX MX9305152A patent/MX9305152A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994004148A1 (fr) | 1994-03-03 |
ZA936137B (en) | 1994-02-21 |
GB9218027D0 (en) | 1992-10-14 |
MX9305152A (es) | 1994-05-31 |
IL106751A0 (en) | 1993-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5016593A (en) | Apparatus for the diagnosis of sleep apnea | |
AU4738496A (en) | External fixator for distal radius fractures | |
AU1532492A (en) | Use of heterocyclic compounds for the treatment of inflammatory pain | |
AU4048295A (en) | Peptide medicaments for the treatment of disease | |
AU3938493A (en) | Percutaneous surgical endoscopy | |
HU9300536D0 (en) | Compounds of medical effect | |
AU1197992A (en) | The use of loperamide and related compounds for treatment of respiratory disease symptoms | |
HU9502520D0 (en) | Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives | |
AU3628395A (en) | Benz{g}indazolyl derivatives for the treatment of inflaminflammation | |
AU4967193A (en) | Use of macrolide compounds for the treatment of reversible obstructive airways disease | |
AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
AU2806692A (en) | Medicament for the treatment of anxiety | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
IL115320A0 (en) | Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases | |
AU1530195A (en) | Halogenated derivatives of 2,3'-(o)-cyclocytidine compounds and process for production thereof | |
AU8185491A (en) | Treatment of disease | |
AU1807592A (en) | New combination preparation for treatment of parkinson's disease | |
AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
EP0755262A4 (fr) | Composition de traitement de pneumopathie | |
AU7750794A (en) | Use of hydroxychloroquine for treatment of graft-versus-host disease | |
AU697487B2 (en) | Therapeutic agent for ischemic diseases | |
AU1320195A (en) | Use of pyridone derivatives as anesthetic drugs | |
GB9021113D0 (en) | New use of macrolide compounds for active oxygen-mediated diseases | |
AU6097394A (en) | Method for the treatment of respiratory disease | |
AU4825993A (en) | New compounds for use in the treatment of cancer |